scanX
Home
Sun Pharmaceutical

Sun Pharmaceutical

1,767.00
-10.25
(-0.58%)
Market Cap (₹ Cr.)
₹4,25,930
52 Week High
1,960.35
Book Value
₹265
52 Week Low
1,184.50
PE Ratio
38.00
PB Ratio
6.16
PE for Sector
37.21
PB for Sector
3.95
ROE
14.38 %
ROCE
16.54 %
Dividend Yield
0.76 %
EPS
₹43.95
Industry
Pharmaceuticals
Sector
Pharmaceuticals - Indian - Bulk Drugs & Formln
Live Chart
comparison:

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Growth Rate
Revenue Growth
12.06 %
Net Income Growth
12.70 %
Cash Flow Change
144.69 %
ROE
-0.38 %
ROCE
14.99 %
EBITDA Margin (Avg.)
4.47 %

Financial Results

Quarterly Financials
Mar 2015
Jun 2015
Sept 2015
Dec 2015
Mar 2016
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Revenue
1,961
2,104
1,889
1,928
2,287
1,926
2,327
2,028
2,032
1,821
2,716
2,442
2,858
3,048
3,006
2,289
3,231
3,328
3,632
3,029
4,055
2,984
3,615
3,901
3,706
3,733
4,427
4,076
4,307
4,982
5,327
4,714
6,069
4,630
5,203
5,151
5,758
4,581
5,214
Expenses
2,563
2,243
2,184
1,787
2,038
1,868
2,025
1,962
1,833
2,914
1,907
1,936
2,145
2,162
3,519
2,087
1,994
2,367
2,538
2,308
2,608
2,241
3,092
3,062
3,050
3,444
3,279
3,114
4,662
3,483
3,622
3,646
6,525
3,667
3,710
3,785
3,746
3,737
3,789
EBITDA
-602
-139
-295
142
249
58
302
66
199
-1,093
808
506
713
886
-513
202
1,238
961
1,093
721
1,447
743
523
839
656
289
1,149
962
-355
1,499
1,705
1,067
-457
963
1,493
1,366
2,012
844
1,425
Operating Profit %
-53 %
-19 %
-19 %
4 %
-22 %
-7 %
-3 %
-5 %
6 %
-69 %
-8 %
18 %
18 %
27 %
-47 %
5 %
12 %
22 %
21 %
21 %
5 %
23 %
11 %
21 %
16 %
6 %
20 %
17 %
-17 %
28 %
30 %
20 %
-12 %
16 %
26 %
23 %
32 %
15 %
26 %
Depreciation
325
110
120
115
120
105
104
105
107
110
105
120
123
156
131
134
132
136
139
144
142
143
306
305
322
307
334
355
354
375
384
430
412
415
393
400
393
370
286
Interest
111
144
182
167
82
101
7
114
1
83
130
65
111
137
151
133
119
57
114
99
138
69
16
74
105
107
104
85
91
87
93
131
161
158
194
215
218
216
244
Profit Before Tax
-1,038
-392
-597
-139
47
-148
191
-153
90
-1,286
574
321
479
594
-795
-65
986
768
840
478
1,167
532
201
460
229
-125
711
521
-800
1,037
1,228
506
-1,030
390
907
751
1,402
258
896
Tax
-959
4
3
3
-4
3
3
5
-6
3
-3
1
-25
0
11
-26
-82
5
16
9
11
-0
-23
-7
44
13
-98
5
486
25
15
19
-9
9
18
30
534
20
32
Net Profit
-79
-396
-600
-142
51
-151
187
-158
96
-1,288
577
321
505
593
-806
-39
1,068
763
823
469
1,156
532
224
467
185
-138
809
515
-1,286
1,012
1,213
487
-1,021
381
889
721
868
238
863
EPS in ₹
-0.30
-1.60
-2.50
-0.60
0.20
-0.60
0.80
-0.70
0.40
-5.37
2.41
1.34
2.10
2.47
-3.36
-0.16
4.45
3.18
3.43
1.95
4.82
2.22
0.90
1.90
0.80
-0.60
3.40
2.10
-5.40
4.20
5.10
2.00
-4.30
1.60
3.70
3.00
3.60
1.00
3.60
Above figures are in Rs. Crores

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
37,446
34,267
33,869
36,792
37,714
38,410
43,735
40,766
40,988
41,065
Fixed Assets
3,185
3,575
4,039
4,645
4,978
5,229
9,669
9,713
8,712
7,737
Current Assets
5,450
5,316
6,388
9,575
11,170
11,941
12,730
9,704
16,444
14,913
Capital Work in Progress
1,091
768
1,101
988
643
597
1,090
829
853
766
Investments
94
22,372
19,333
18,355
17,904
17,362
15,537
15,549
12,613
12,430
Other Assets
33,076
7,553
9,397
12,804
14,189
15,223
17,438
14,675
18,810
20,132
Total Liabilities
14,659
12,376
12,857
14,469
14,871
14,014
16,796
16,178
17,239
17,370
Current Liabilities
11,052
8,627
10,963
12,558
13,272
11,204
9,951
10,106
8,365
4,445
Non Current Liabilities
3,607
3,748
1,894
1,911
1,599
2,810
6,845
6,072
8,874
12,926
Total Equity
22,786
21,891
21,013
22,323
22,844
24,396
26,939
24,588
23,748
23,694
Reserve & Surplus
22,579
21,650
20,773
22,083
22,604
24,156
26,699
24,348
23,508
23,455
Share Capital
207
241
240
240
240
240
240
240
240
240
Above figures are in Rs. Crores

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
117
17
7
-50
205
-82
36
68
-9
-84
Investing Activities
2,642
3,640
2,381
1,394
431
1,483
1,452
-2,697
-686
-265
Operating Activities
149
-1,254
-1,621
-1,171
1,242
1,306
-417
7,636
507
-292
Financing Activities
-2,674
-2,368
-753
-272
-1,469
-2,871
-1,000
-4,871
169
474
Above figures are in Rs. Crores

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Promoter
54.48 %
54.48 %
54.48 %
54.48 %
54.48 %
54.48 %
54.48 %
54.48 %
54.48 %
54.48 %
54.48 %
54.48 %
54.48 %
54.48 %
54.48 %
FIIs
11.67 %
11.50 %
12.07 %
13.00 %
14.44 %
14.95 %
15.99 %
16.87 %
16.89 %
16.48 %
16.79 %
17.07 %
17.72 %
17.22 %
18.02 %
DIIs
21.62 %
21.97 %
21.72 %
21.00 %
20.02 %
19.66 %
19.71 %
19.14 %
19.25 %
19.75 %
19.67 %
19.53 %
18.83 %
19.28 %
18.61 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
12.23 %
12.05 %
11.72 %
11.53 %
11.06 %
10.91 %
9.82 %
9.51 %
9.39 %
9.29 %
9.06 %
8.92 %
8.97 %
9.01 %
8.89 %

Dividend History

Peer Comparison Compare Peers on Screener

Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
Sun Pharmaceutical
1,769.95 4,25,929.94 38.00 49,887.17 12.06 9,648 27.35 40.28
Cipla
1,460.90 1,18,825.56 25.74 26,520.66 14.17 4,155 12.95 38.47
Mankind Pharma
2,522.00 1,02,885.42 48.65 10,615.63 19.57 1,942 28.89 46.80
Dr Reddys Laboratories
1,194.00 1,01,290.13 18.97 28,905.40 12.36 5,578 -9.47 32.64
Zydus Life Science
943.30 95,280.30 22.27 19,831.50 13.82 3,831 14.57 32.02
Lupin
2,039.10 92,929.19 35.38 20,141.50 19.94 1,936 73.52 37.01
Aurobindo Pharma
1,219.05 73,119.28 20.05 29,559.25 17.55 3,169 8.65 20.74
Alkem Laboratories
5,590.05 66,062.65 30.38 12,978.42 9.84 1,811 14.16 35.74
Glenmark Pharmaceuticals
1,463.95 42,112.35 - 12,653.09 6.58 -1,831 675.84 30.08
IPCA Laboratories
1,569.70 39,910.21 59.43 7,829.81 22.92 529 80.05 52.38

Corporate Action

Technical Indicators

RSI(14)
Neutral
40.28
ATR(14)
Volatile
43.37
STOCH(9,6)
Neutral
21.35
STOCH RSI(14)
Oversold
15.45
MACD(12,26)
Bearish
-7.52
ADX(14)
Strong Trend
31.69
UO(9)
Bearish
35.98
ROC(12)
Downtrend But Slowing Down
-4.04
WillR(14)
Neutral
-75.48
Bearish
4
Neutral
3
Bullish
2
raisewe are part of Raise Financial Services
Heart
built with love

for indians who love to invest & trade

Explore   |   Sitemap
Intraday Screeners
Price & Volume Screeners
Technical Screeners
Candlestick Screeners
Fundamental Screeners
Bullish Stocks Today
Bearish Stocks Today
Stocks Nearing 52W High & Low
Rise & Fall Stocks
Index
Sector
Stock Heatmap
Companies
About Scanx

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation. We plan to change that - a technology-led platform built for super traders and long term investors.

© 2024 Moneylicious Securities Pvt. Ltd. All rights reserved.

Part of Raise Financial Services

Corporate Office: A-302, The Western Edge I, Off Western Express Highway, Borivali East, Mumbai – 400066, Maharashtra, India. Land Line: 022-43116666.